DAFNA Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-556,695
| Closed | -$4.38M | – | 79 |
|
|
2023
Q3 | $4.38M | Hold |
556,695
| – | – | 1.36% | 24 |
|
|
2023
Q2 | $5.56M | Sell |
556,695
-10,000
| -2% | -$99.9K | 1.52% | 21 |
|
|
2023
Q1 | $5.03M | Hold |
566,695
| – | – | 1.51% | 22 |
|
|
2022
Q4 | $6.22M | Hold |
566,695
| – | – | 1.75% | 17 |
|
|
2022
Q3 | $7.38M | Hold |
566,695
| – | – | 1.99% | 16 |
|
|
2022
Q2 | $7.18M | Buy |
566,695
+23,351
| +4% | +$296K | 1.96% | 14 |
|
|
2022
Q1 | $7.61M | Buy |
543,344
+237,024
| +77% | +$3.32M | 1.98% | 13 |
|
|
2021
Q4 | $8.87M | Hold |
306,320
| – | – | 2.23% | 10 |
|
|
2021
Q3 | $9.18M | Hold |
306,320
| – | – | 2.43% | 9 |
|
|
2021
Q2 | $8.13M | Hold |
306,320
| – | – | 1.7% | 13 |
|
|
2021
Q1 | $9.52M | Buy |
+306,320
| New | +$9.52M | 2.26% | 7 |
|